Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

6 Stocks To Watch: ARWR, FATE, HUYA, HYRE, QURE, RCKT

Published 02/26/2019, 12:10 AM
Updated 07/09/2023, 06:31 AM

The markets had a very interesting day on Monday, up sharply with big gaps in the morning on more positive trade news, they consolidated, reached a higher-high, and then had a long decline to the session lows, but still closed up on the day. Advance-declines were sloppy, nearly flat on both exchanges, and the up/down volume was nothing to speak about at 5 to 3 on both exchanges as well. A lot of stocks we follow did well, and here are a few I want to show you.

Arrowhead Pharmaceuticals, Inc. (ARWR)

ARWR continues to act well, popping another 72 cents, or 3.9% to 19.12, on 1.9 million shares on Monday. You can see the rising channel extends. I’m looking for a test of the 20.20-.30 range. That may happen quickly and shortly. The secondary target is 23 going forward.

Fate Therapeutics, Inc. (FATE)

FATE popped out of a mini, inverse head-and-shoulders. It had a nice run-up of 1.85. or 12.83%, to 16.27, on 1.2 million shares. The volume picked up. It was the best volume on an up-day in three months. I’m looking for a test of 17 3/4-18, and then 23.

HyreCar Inc. (HYRE)

HYRE had a big day on Monday. It had a swing put on it on Friday, and had a nice follow-through on Monday, up 35 cents, or 7%, to 5.34, on 1.7 million shares. I’m still looking for 6.35-.45, and eventually 8.00-9.00.

uniQure N.V. (QURE)

QURE had a huge day on Monday, exploding 14.27, or 34%, to 55.87, on over 4 million shares. That’s the biggest day I’ve even seen for this stock. The long-term channel tells me this is not done until it gets to 80.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Rocket Pharmaceuticals, Inc. (RCKT)

RCKT has an inverse head-and-shoulders that popped on Monday, jumping 1.73, or 11.63%, to 16.61, on 363,452 shares traded. It closed right on the neckline. Any follow-through here will take it to 18 1/2, and then 21-22.

Stocks On The Long Side

Akcea Therapeutics, Inc. (AKCA), Arrowhead Pharmaceuticals, Inc. (ARWR), Aurinia Pharmaceuticals Inc. (AUPH), bluebird bio, Inc. (BLUE), Audentes Therapeutics, Inc. (BOLD), China Internet Nationwide Financial Services Inc. (CIFS), CRISPR Therapeutics AG (CRSP), Community Health Systems, Inc. (CYH), Fate Therapeutics, Inc. (FATE), Phoenix New Media Limited (FENG), Amicus Therapeutics, Inc. (FOLD), Farfetch Limited (FTCH), General Electric Company (NYSE:GE), HUYA Inc. (HUYA), HyreCar Inc. (HYRE), nLIGHT, Inc. (LASR), NIO Inc. (NIO), Pyxus International, Inc. (PYX), Qudian Inc. (QD), uniQure N.V. (QURE), Rocket Pharmaceuticals, Inc. (RCKT), StoneCo Ltd. (STNE), China SXT Pharmaceuticals, Inc. (SXTC), Veritone, Inc. (VERI), Weibo Corporation (WB), and Zosano Pharma Corporation (ZSAN).

Watch video here.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.